Details for New Drug Application (NDA): 215744
✉ Email this page to a colleague
The generic ingredient in DOCETAXEL is docetaxel. There are forty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the docetaxel profile page.
Pharmacology for NDA: 215744
Physiological Effect | Microtubule Inhibition |
Suppliers and Packaging for NDA: 215744
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 215744 | ANDA | Alembic Pharmaceuticals Limited | 46708-678 | 46708-678-02 | 1 VIAL, SINGLE-DOSE in 1 CARTON (46708-678-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 215744 | ANDA | Alembic Pharmaceuticals Limited | 46708-678 | 46708-678-08 | 1 VIAL, MULTI-DOSE in 1 CARTON (46708-678-08) / 8 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 20MG/2ML (10MG/ML) | ||||
Approval Date: | Feb 28, 2023 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 80MG/8ML (10MG/ML) | ||||
Approval Date: | Feb 28, 2023 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 160MG/16ML (10MG/ML) | ||||
Approval Date: | Feb 28, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription